Health economics simulation model

health economic simulation1


The MS Research Flagship has developed a health economics simulation model to assess the impact of MS treatments. Drug therapies, lifestyle interventions, public health programs, medical devices and/or surgical interventions can all be evaluated using the model.

The model can be used for multiple purposes to estimate the impact of interventions on clinical and cost outcomes of MS, as well as a range of economic analyses (cost-effectiveness, cost-utility or cost of disease). It can also be used to identify potential high risk patient profiles.

The economic model is available to clinicians, researchers and policy makers to ensure optimal disease course management of MS and the most efficient use of limited health care resources.


The outputs from the model may include:

  • Life expectancy
  • Quality-adjusted life years
  • Direct costs
  • Indirect costs (productivity losses)
  • Probabilistic sensitivity analysis, including scatter plots and cost-effectiveness acceptability curves
  • Survival curves
  • Incremental cost-effectiveness ratios

How to collaborate

The model is run on a server housed at Menzies Institute for Medical Research, University of Tasmania (UTAS). An online user interface, powered by TreeAge Decision Analysis software, provides access to an independent, gold standard, validated, user friendly, transparent, decision analysis model. You do not need TreeAge software to run the model.

Applicants will need to agree to the UTAS privacy policy and the end user license agreement to access the model.

To access the model download the request form complete it and email to us

For more information contact us.

Please note we have ~10 business day turnaround time.

Funded by

MRFF logo_BMSA_logo with tagline

Funding for this initiative has been provided by the Australian government's Medical Research Future Fund (MRFF) and MS Australia.